Showing 1 - 10 of 18
Persistent link: https://www.econbiz.de/10010425165
There are two salient facts about health care in low and middle-income countries; 1) the private sector plays an important role and 2) the care provided is often of poor quality. Despite these facts we know little about what drives quality of care in the private sector and why patients continue...
Persistent link: https://www.econbiz.de/10012480403
Persistent link: https://www.econbiz.de/10012166004
There are two salient facts about health care in low and middle-income countries; 1) the private sector plays an important role and 2) the care provided is often of poor quality. Despite these facts we know little about what drives quality of care in the private sector and why patients continue...
Persistent link: https://www.econbiz.de/10013323878
Persistent link: https://www.econbiz.de/10011545945
Persistent link: https://www.econbiz.de/10003841134
Persistent link: https://www.econbiz.de/10009710440
Rewarding inventors with inefficient monopoly power has long been regarded as the price of encouraging innovation. Public prescription drug insurance escapes that trade-off and achieves an elusive goal: lowering static deadweight loss, while simultaneously encouraging dynamic investments in...
Persistent link: https://www.econbiz.de/10012465145
Rewarding inventors with inefficient monopoly power has long been regarded as the price of encouraging innovation. Public prescription drug insurance escapes that trade-off and achieves an elusive goal: lowering static deadweight loss, while simultaneously encouraging dynamic investments in...
Persistent link: https://www.econbiz.de/10012775801
Persistent link: https://www.econbiz.de/10014288035